Geneive E. Henry

1.0k total citations
30 papers, 856 citations indexed

About

Geneive E. Henry is a scholar working on Molecular Biology, Organic Chemistry and Pharmacology. According to data from OpenAlex, Geneive E. Henry has authored 30 papers receiving a total of 856 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 11 papers in Organic Chemistry and 11 papers in Pharmacology. Recurrent topics in Geneive E. Henry's work include Natural Compound Pharmacology Studies (10 papers), Synthesis of Organic Compounds (9 papers) and Synthesis and biological activity (4 papers). Geneive E. Henry is often cited by papers focused on Natural Compound Pharmacology Studies (10 papers), Synthesis of Organic Compounds (9 papers) and Synthesis and biological activity (4 papers). Geneive E. Henry collaborates with scholars based in United States, Jamaica and Canada. Geneive E. Henry's co-authors include Navindra P. Seeram, Muraleedharan G. Nair, Helen Jacobs, David L. DeWitt, Stewart McLean, William F. Reynolds, Liya Li, C. M. Sean Carrington, Antonio González‐Sarrías and Daniel B. Niesen and has published in prestigious journals such as The Journal of Physical Chemistry B, Journal of Agricultural and Food Chemistry and Tetrahedron.

In The Last Decade

Geneive E. Henry

30 papers receiving 835 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Geneive E. Henry United States 15 336 328 194 171 95 30 856
Jan A. Gliński United States 19 482 1.4× 156 0.5× 91 0.5× 177 1.0× 95 1.0× 44 1.1k
Joonseok Oh United States 22 826 2.5× 271 0.8× 233 1.2× 181 1.1× 86 0.9× 69 1.5k
Eliane Garo Switzerland 17 467 1.4× 207 0.6× 213 1.1× 156 0.9× 128 1.3× 32 874
Leonardo Noboru Seito Brazil 17 339 1.0× 220 0.7× 137 0.7× 170 1.0× 153 1.6× 23 905
Matthias Unger Germany 22 488 1.5× 207 0.6× 221 1.1× 148 0.9× 60 0.6× 52 1.2k
Carla Bassarello Italy 21 569 1.7× 474 1.4× 259 1.3× 304 1.8× 89 0.9× 50 1.1k
Zhenhua Qiao China 7 446 1.3× 236 0.7× 164 0.8× 171 1.0× 137 1.4× 24 1.1k
George Lambrinidis Greece 18 581 1.7× 96 0.3× 70 0.4× 155 0.9× 33 0.3× 53 1.1k
Jaroslav Vičar Czechia 15 423 1.3× 176 0.5× 381 2.0× 126 0.7× 77 0.8× 26 972
Aline Witaicenis Brazil 11 257 0.8× 140 0.4× 120 0.6× 158 0.9× 112 1.2× 14 689

Countries citing papers authored by Geneive E. Henry

Since Specialization
Citations

This map shows the geographic impact of Geneive E. Henry's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Geneive E. Henry with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Geneive E. Henry more than expected).

Fields of papers citing papers by Geneive E. Henry

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Geneive E. Henry. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Geneive E. Henry. The network helps show where Geneive E. Henry may publish in the future.

Co-authorship network of co-authors of Geneive E. Henry

This figure shows the co-authorship network connecting the top 25 collaborators of Geneive E. Henry. A scholar is included among the top collaborators of Geneive E. Henry based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Geneive E. Henry. Geneive E. Henry is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cassel, Joel, et al.. (2024). Synthesis, SARS-CoV-2 main protease inhibition, molecular docking and in silico ADME studies of furanochromene-quinoline hydrazone derivatives. Bioorganic & Medicinal Chemistry Letters. 102. 129679–129679. 2 indexed citations
2.
Timms, E., Huifang Li, Michael A. Parra, et al.. (2023). Synthesis, anti-ferroptosis, anti-quorum sensing, antibacterial and DNA interaction studies of chromene-hydrazone derivatives. Bioorganic & Medicinal Chemistry. 90. 117369–117369. 4 indexed citations
3.
Li, Huifang, et al.. (2022). Phenolic furanochromene hydrazone derivatives: Synthesis, antioxidant activity, ferroptosis inhibition, DNA cleavage and DNA molecular docking studies. Bioorganic & Medicinal Chemistry. 75. 117088–117088. 5 indexed citations
4.
McMillen, Colin D., et al.. (2022). Chromene-based Schiff base ligand: DNA interaction studies and characterization of tetranuclear zinc, nickel and iron complexes. Inorganica Chimica Acta. 547. 121363–121363. 7 indexed citations
5.
Seeram, Navindra P., et al.. (2019). Heterocyclic β-keto sulfide derivatives of carvacrol: Synthesis and copper (II) ion reducing capacity. Bioorganic & Medicinal Chemistry Letters. 29(19). 126636–126636. 8 indexed citations
6.
Seeram, Navindra P., et al.. (2019). Synthesis and evaluation of apoptotic induction of human cancer cells by ester derivatives of thujone. Medicinal Chemistry Research. 29(2). 268–280. 2 indexed citations
7.
Niesen, Daniel B., Hang Ma, Tao Yuan, et al.. (2015). Phenolic Constituents of Carex vulpinoidea Seeds and their Tyrosinase Inhibitory Activities. Natural Product Communications. 10(3). 491–3. 10 indexed citations
8.
Suiter, Christopher L., Geneive E. Henry, James Rovnyak, et al.. (2015). Sensitivity of Nonuniform Sampling NMR. The Journal of Physical Chemistry B. 119(22). 6502–6515. 79 indexed citations
9.
Petrunak, Elyse M., et al.. (2011). Acylphloroglucinol and xanthones from Hypericum ellipticum. Phytochemistry. 72(7). 662–667. 14 indexed citations
10.
Janssen, M. J., et al.. (2011). Inhibition of Bacterial Growth and Biofilm Production by Constituents from Hypericum spp.. Phytotherapy Research. 26(7). 1012–1016. 27 indexed citations
11.
Henry, Geneive E., Yun‐Bao Liu, Liya Li, et al.. (2009). Bioactive acylphloroglucinols from Hypericum densiflorum. Phytotherapy Research. 23(12). 1759–1762. 20 indexed citations
12.
Petrunak, Elyse M., et al.. (2009). New Benzophenone O-Glucoside from Hypericum Ellipticum. Natural Product Communications. 4(4). 507–10. 5 indexed citations
13.
Henry, Geneive E., et al.. (2006). Kaurene diterpenes from Laetia thamnia inhibit the growth of human cancer cells in vitro. Cancer Letters. 244(2). 190–194. 21 indexed citations
14.
Henry, Geneive E., Smita Raithore, Yanjun Zhang, et al.. (2006). Acylphloroglucinol Derivatives from Hypericum prolificum. Journal of Natural Products. 69(11). 1645–1648. 22 indexed citations
15.
Henry, Geneive E., et al.. (2002). Antioxidant and Cyclooxygenase Activities of Fatty Acids Found in Food. Journal of Agricultural and Food Chemistry. 50(8). 2231–2234. 196 indexed citations
16.
17.
Henry, Geneive E. & Helen Jacobs. (2001). A short synthesis of 5-methoxy-2,2-dimethyl-2 H -1-benzopyran-6-propanoic acid methyl ester. Tetrahedron. 57(25). 5335–5338. 20 indexed citations
18.
Harding, Wayne W., Geneive E. Henry, Patrick A. Lewis, et al.. (1998). Alvaradoins A−D. Anthracenone C Arabinosides from Alvaradoa jamaicensis. Journal of Natural Products. 62(1). 98–101. 14 indexed citations
19.
Henry, Geneive E., Helen Jacobs, C. M. Sean Carrington, Stewart McLean, & William F. Reynolds. (1996). Plukenetione A. An unusual adamantyl ketone from Clusia plukenetii (guttiferae). Tetrahedron Letters. 37(48). 8663–8666. 47 indexed citations
20.
Henry, Geneive E., et al.. (1995). Xerophenones A and B. New isoprenylated derivatives of 11-oxatricyclo[4.3.1.14,10]undecane-7,9-dione from Clusia portlandiana (Guttiferae). Tetrahedron Letters. 36(26). 4575–4578. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jan A. Gliński Breakdown of academic impact, for papers by Joonseok Oh Breakdown of academic impact, for papers by Eliane Garo Breakdown of academic impact, for papers by Leonardo Noboru Seito Breakdown of academic impact, for papers by Matthias Unger Breakdown of academic impact, for papers by Carla Bassarello Breakdown of academic impact, for papers by Zhenhua Qiao Breakdown of academic impact, for papers by George Lambrinidis Breakdown of academic impact, for papers by Jaroslav Vičar Breakdown of academic impact, for papers by Aline Witaicenis
Rankless by CCL
2026